期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Journal of Integrative Medicine-JIM LetPub Score 7.0
50 ratings
Rate
Reputation 8.8 Influence 5.5 Speed 7.0 | ||||||||||||||||
期刊簡稱 | J INTEGR MED-JIM | ||||||||||||||||
ISSN | 2095-4964 | ||||||||||||||||
h-index | N.A. | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 2.40%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.journals.elsevier.com/journal-of-integrative-medicine | ||||||||||||||||
在線稿件提交 | |||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Elsevier | ||||||||||||||||
主題領域 | Medicine | ||||||||||||||||
出版國/地區 | PEOPLES R CHINA | ||||||||||||||||
發行頻率 | |||||||||||||||||
創刊年 | 0 | ||||||||||||||||
每年文章數 | 56每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 13.22% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2095-4964%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Journal of Integrative Medicine-JIM] 的評論 | 撰寫評論 |
作者: baidulyac 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-18 12:18:02 評論於 Between 55-60 papers are published every year, and it's only October, with over 1300 already. At least 1500 will be published in a year, with an acceptance rate of less than 4%.(0) 讚! | baidulyac |
作者: XIAOGUOQIU 領域: 医学 審稿時間: 2.0 month(s) 結果: 拒稿 撰寫評論 |
2020-08-12 19:33:01 評論於 It took a total of 2 months and 1 day from submission to rejection. It was notified to revise the manuscript in one month. It was submitted after revision, and got rejected one month later. The reason for rejection was completely different from the first revision. But it was also pertinent. The review speed is moderate. (0) 讚! | XIAOGUOQIU |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us